High Tower Advisors, LLC Sorrento Therapeutics, Inc. Put Options Transaction History

High Tower Advisors, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 08, 2023	BUY	$0.74 - $1.83 $177 - $439	240 Added 85.71%	520 $0
Q3 2022 Nov 09, 2022	SELL	$1.51 - $2.88 $23,737 - $45,273	-15,720 Reduced 98.25%	280 $8,000
Q2 2022 Aug 10, 2022	BUY	$1.24 - $2.33 $19,505 - $36,650	15,730 Added 5825.93%	16,000 $3,000
Q4 2021 Feb 10, 2022	SELL	$4.65 - $7.23 $258,679 - $402,204	-55,630 Reduced 99.52%	270 $7,000
Q3 2021 Nov 12, 2021	BUY	$7.41 - $10.99 $412,292 - $611,483	55,640 Added 21400.0%	55,900 $39,000
Q1 2021 May 10, 2021	BUY	$7.03 - $16.51 $1,827 - $4,292	260 New	260 $25,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.